S2Medical AB (publ) (STO:S2M)
Sweden · Delayed Price · Currency is SEK 0.0084
+0.0006 (7.69%)
Apr 24, 2026, 1:38 PM CET
S2Medical AB Market Cap
S2Medical AB has a market cap or net worth of 7.62 million as of April 24, 2026. Its market cap has decreased by -14.08% in one year.
Market Cap
7.62M
Enterprise Value
6.71M
Revenue
16.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since November 28, 2018, S2Medical AB's market cap has decreased from 214.61M to 7.62M, a decrease of -96.45%. That is a compound annual growth rate of -36.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 7.07M | -21.70% |
| Dec 30, 2025 | 9.03M | 1.90% |
| Dec 30, 2024 | 8.86M | -46.36% |
| Dec 29, 2023 | 16.53M | -25.20% |
| Dec 30, 2022 | 22.09M | -72.04% |
| Dec 30, 2021 | 79.02M | -12.55% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 140.41B |
| Getinge AB | 53.38B |
| Sectra AB | 52.14B |
| Camurus AB | 33.97B |
| Enorama Pharma AB | 20.06M |
| Guard Therapeutics International AB | 19.20M |
| Fluicell AB | 18.27M |
| Gabather AB | 17.50M |